Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ARYA SCIENCES ACQUISITION CORP IV

(ARYD)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ARYA Sciences Acquisition Corp IV announced that it expects to receive $4.6 million in funding from Arya Sciences Holdings Iv

02/10/2021 EST

ARYA Sciences Acquisition Corp IV announced that it has entered into a purchase agreement with Arya Sciences Holdings Iv for a private placement of 460,000 Class A shares at an issue price of $10 per shares for gross proceeds of $4,600,000 on February 10, 2021. The underwriters have been granted an over-allotment option to issue up to 499,000 shares at a price of $10 per shares for gross proceeds of $4,990,000 in the transaction. The warrants are subject to a lock-up period of 1 year after the completion of our initial business combination. The transaction is expected to close along with the IPO.


© S&P Capital IQ 2021
All news about ARYA SCIENCES ACQUISITION CORP IV
11/12ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Ni..
CI
11/09ARYA Sciences Acquisition Corp IV Provides Earnings Guidance for the Year 2021
CI
09/30AMICUS THERAPEUTICS : and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-G..
AQ
09/29Health Care Stocks Easing Slightly From Intra-Day Highs Near Close
MT
09/29Health Care Stocks Recovering From Tuesday Selloff
MT
09/29ARYA SCIENCES ACQUISITION IV : Business Combination of Amicus Gene Therapy Business with A..
PU
09/29AMICUS THERAPEUTICS : Arya Sciences Acquisition Corp to Create Genetic Medicine Company Ca..
MT
09/29Gene Therapy Business of Amicus Therapeutics, Inc. entered into a definitive business c..
CI
08/24Certain Class B Ordinary Shares of ARYA Sciences Acquisition Corp IV are subject to a L..
CI
08/12Arya Sciences Acquisition Corp Iv Reports Earnings Results for the Second Quarter Ended..
CI
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -0,01 M - -
Net Debt 2020 - - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 190 M 190 M -
EV / Sales 2019
Capi. / Sales 2020 -
Nbr of Employees -
Free-Float 77,9%
Chart ARYA SCIENCES ACQUISITION CORP IV
Duration : Period :
ARYA Sciences Acquisition Corp IV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ARYA SCIENCES ACQUISITION CORP IV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Adam Leo Stone Chief Executive Officer & Director
Michael R. Altman Chief Financial Officer & Director
Joseph Eric Edelman Chairman
Todd Wider Independent Director
Leslie L. Trigg Independent Director
Sector and Competitors